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Multiple epiphyseal dysplasia (MED) is an autosomal dominantly inherited chondrodysplasia. It is clinically highly
heterogeneous, partially because of its complex genetic background. Mutations in four genes, COL9A2, COL9A3,
COMP, andMATR3, all coding for cartilage extracellular matrix components (i.e., the a2 and a3 chains of collagen
IX, cartilage oligomeric matrix protein, and matrilin-3), have been identified in this disease so far, but no mutations
have yet been reported in the third collagen IX gene, COL9A1, which codes for the a1(IX) chain. MED with
apparently recessive inheritance has been reported in some families. A homozygous R279W mutation was recently
found in the diastrophic dysplasia sulfate transporter gene, DTDST, in a patient with MED who had a club foot
and double-layered patella. The series consisted of 41 probands with MED, 16 of whom were familial and on 4
of whom linkage analyses were performed. Recombination was observed between COL9A1, COL9A2, COL9A3,
and COMP and the MED phenotype in two of the families, and between COL9A2, COL9A3, and COMP and
the phenotype in the other two families. Screening of COL9A1 for mutations in the two probands from the families
in which this gene was not involved in the recombinations failed to identify any disease-causing mutations. The
remaining 37 probands were screened for mutations in all three collagen IX genes and in the COMP gene. The
probands with talipes deformities or multipartite patella were also screened for the R279W mutation in DTDST.
The analysis resulted in identification of three mutations in COMP and one in COL9A1, but none in the other
two collagen IX genes. Two of the probands with a multipartite patella had the homozygous DTDST mutation.
The results show that mutations in COL9A1 can cause MED, but they also suggest that mutations in COL9A1,
COL9A2, COL9A3, COMP, and DTDST are not the major causes of MED and that there exists at least one
additional locus.
Introduction
Multiple epiphyseal dysplasia (MED [MIM 132400]) is
a disorder of the skeletal system that is manifested as a
disturbance in the development of the epiphyses (Fair-
bank 1947), the major component of which is cartilage.
The changes are usually observed in the majority of the
growth centers, including those of the spine (Hoefnagel
1967). The joints are usually bilaterally—but not always
symmetrically—affected in MED.
The first symptoms of MED occur in childhood, usu-
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ally at age 2–14 years, and include waddling gait, re-
striction of joint mobility, and pain and stiffness in the
weight-bearing joints. MED is clinically heterogeneous,
consisting of the Fairbank, Ribbing, and unclassified
types (International Working Group on Constitutional
Diseases of Bone 1998). The Fairbank type is more se-
vere than the Ribbing type and is characterized by short-
ness of stature; short, stubby fingers; and small epiph-
yses in several joints, including the knee, ankle, hand,
and hip (Fairbank 1947; Silverman 1996). The Ribbing
type (Ribbing 1937; Silverman 1996) is confined pre-
dominantly to the hip joints and is characterized by
hands that are normal and stature that is normal or
near-normal. The unclassified types represent combi-
nations of the Fairbank and Ribbing phenotypes.
Radiological examination of the skeleton shows de-
layed, irregular mineralization of the epiphyseal ossifi-
cation centers and of the centers of the carpal and tarsal
bones (Silverman 1996). Early-onset osteoarthritis (OA)
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is also a very common finding. Some patients with MED
present with mild spinal and patellar abnormalities. The
spinal changes can include irregular end plates of the
vertebral bodies, Schmorl’s nodes, wedging of the ver-
tebral bodies, and narrowed disc spaces. Some patients
may have ovoid vertebral bodies in the thoraco-lumbar
spine in the first few years of life (Hulvey and Keats 1969;
Silverman 1996). Radiographs of the knees show mul-
tipartite patellae in some MED cases (Sheffield 1998).
The epiphyses are flat in the Ribbing type (Ribbing 1937)
and are small in the Fairbank type (Silverman 1996).
MED is an autosomal dominantly inherited osteo-
chondrodysplasia for which four loci have been iden-
tified so far: EDM1 (MIM 132400), EDM2 (MIM
600204), EDM3 (MIM 600969), and EDM5 (Chap-
man et al. 2001). EDM1 is located on chromosome
19p13.1 (Newton et al. 1994) and contains a gene for
cartilage oligomeric matrix protein (COMP [MIM
600310]) (Oehlmann et al. 1994). Eleven mutations in
COMP have been identified in the Ribbing, Fairbanks,
and unclassified forms of the disease (Briggs et al. 1995,
1998; Ballo et al. 1997; Susic et al. 1997; Ikegawa et
al. 1998; Loughlin et al. 1998; Deere et al. 1999; De´lot
et al. 1999), and ∼40 mutations have been identified in
pseudoachondroplasia (PSACH [MIM 177170]), an al-
lelic disorder (Deere et al. 1998, 1999; Ikegawa et al.
1998; De´lot et al. 1999; Newman et al. 2000). The other
two MED loci contain genes for collagen IX—namely,
COL9A2 (MIM 120260) on chromosome 1p32.3-p33
(Warman et al. 1994) and COL9A3 (MIM 120270) on
chromosome 20q13.3 (Brewton et al. 1995). Four mu-
tations have been identified in the COL9A2 gene (Mur-
agaki et al. 1996; Holden et al. 1999; Spayde et al.
2000), and three have been identified in the COL9A3
gene (Paassilta et al. 1999a; Bonneman et al. 2000; Loh-
iniva et al. 2000). Recently, Chapman and others (2001)
identified a new MED locus, EDM5. It is located on
chromosome 2p24-p23 and contains a gene for matri-
lin-3 (MATN3 [MIM 602109]). Two different missense
mutations were reported in the exon encoding the von
Willebrand factor A domain of matrilin-3 in two un-
related families with MED (Chapman et al. 2001).
COMP is an extracellular matrix glycoprotein of 524
kD that belongs to the thrombospondin protein family
(Hedbom et al. 1992; Mo¨rgelin et al. 1992; Oldberg et
al. 1992). It is a bouquet-shaped pentameric molecule
composed of five identical arms (Mo¨rgelin et al. 1992;
Malashkevich et al. 1996), each containing a coiled-coil
N-terminal domain responsible for pentamerization,
four epidermal growth factor–like repeats, eight throm-
bospondin type 3 (T3) repeats, and a large globular C-
terminal domain (Mo¨rgelin et al. 1992; Hummel et al.
1998). Most of the mutations characterized in COMP
in patients with MED or PSACH have been amino acid
substitutions clustered in the T3 repeats (Briggs et al.
1995). It has been shown that such mutations may dis-
turb calcium binding (Misenheimer and Mosher 1995;
Chen et al. 2000; Maddox et al. 2000; Thur et al. 2001).
Collagen IX is a heterotrimer of a1(IX), a2(IX), and
a3(IX) chains encoded by the COL9A1 (MIM 120210),
COL9A2, and COL9A3 genes (Pihlajamaa et al. 1998;
Paassilta et al. 1999b). It is a fibril-associated collagen
with interrupted triple helices, consisting of three collag-
enous (COL1–COL3) and four non-collagenous (NC1–
NC4) domains. It is a quantitatively minor cartilage com-
ponent that is covalently cross-linked to collagen II fibrils
via the COL2 domain (Diab et al. 1996). The NC3 do-
main functions as a hinge, allowing the other two more
N-terminal domains, COL3 and NC4, to project away
from the fibril surface. It has been suggested that these
domains may mediate interactions between collagen IX
and other matrix molecules. The three genes are almost
identical in their genomic organization, with one excep-
tion—the COL9A1 gene contains 38 exons, whereas the
others have 32.
Some families with MED have been reported to have
autosomal recessive MED (EDM4 [MIM 226900]). A
homozygous R279W mutation was found in the dia-
strophic dysplasia sulfate transporter gene (DTDST
[MIM 222600]) in one individual with autosomal re-
cessive MED characterized by club foot and double lay-
ered patella (Superti-Furga et al. 1999). The same ho-
mozygous mutation was recently found in two unrelated
sibships with apparently isolated club foot (Huber et al.
2001).
Here we studied 41 probands with MED, of whom
16 were familial. Recombinations were observed be-
tween COMP, COL9A1, COL9A2, and COL9A3 and
the phenotype in two families and between three of the
genes and the phenotype in another two families. Since
mutations could be identified in only 6 of 39 probands,
we suggest that at least one additional locus must exist
for MED.
Subjects and Methods
Subjects
Forty unrelated probands with MED (probands 1–40,
table 1) were examined in the Departments of Ortho-
paedics and Medical Genetics at the University of Med-
ical Sciences, Poznan, Poland, and in the Department of
Orthopaedics at the University of Medical Sciences,
Szczecin, Poland, and one proband (proband 41, table
1) was examined at the Department of Rheumatology,
St. Thomas’ Hospital, London (proband 41, table 1). A
detailed clinical and radiological examination was per-
formed on all the probands and on most of the affected
family members. Sixteen of the probands had a positive
family history of disease, and 25 had no family history.
Table 1
Clinical and Radiological Findings in the Probands
PROBAND
(SEX)
AGE
AT
ONSET
(years)
CURRENT
AGE
(years)
HEIGHT
(cm)
JOINT
PAIN
CLINICAL FINDINGS RADIOLOGICAL FINDINGS
MUTATION
Joint
Limitation Other
Epiphyses
OA OtherFlat Small Irregular
1 (F) .3 18 172 H H H, K, S, W H
2 (F) 7 50 158 H E, H, K HAa, Kb,c A, K H A, H, K, W D420Ad
3 (F) 7 42 163 K H HAa E, H, K H, K Pe,f, Thg R279Wh
4 (M) 11 40 185 K Kb, Fi K, W K, W K
5 (F) 7 22 160 H H, K Kc K, S H A, H H, K Pf
6 (M) 9 18 174 H H
7 (F) 7 23 170 H A, HA, H, W H H
8 (M) 6 22 176 H, SP H A, H A, H Thg P276Rd
9 (F) 2 17 162 K Fa,j, HAj, Kc A, H K K Thg, Pk
10 (M) 11 17 168 H, K H HAa, Kc A, E, H, K, W T585Md
11 (M) 12 31 170 E, H, K E, H Kc E, K H E, H
12 (M) 2 14 163 K Kb H, K A, H Th-Ll
13 (M) 10 24 182 H H H H
14 (M) 3 41 160 H E, H E, HA, H, K, S H, K H Pf, Th-Lg
15 (M) 6 20 182 K H A, H A, H
16 (M) 12 41 174 H, K H A, H H A, H
17 (M) 1 3 90 H, K Fi, Kb H, K
18 (F) 7 41 152 A, H, K H HAa A, E, HA, H, K K A Pf, Th-Lg
19 (M) 5 42 141 H H Kb S H
20 (M) 0 20 158 HAa HA S, W A Lg
21 (F) 6 19 146 K A K, W K
22 (M) 5 37 164 K, H Fg, Hb A, H, K K Pk, Ll
23 (M) .3 26 172 H, K Fa, HAa, Kb E H E, H, HA, K, S, W
24 (F) 13 22 160 H H H H
25 (F) 7 25 152 H, S, W HAa, Kb H, S Thg,l
26 (M) 1 23 171 H H, K H A, E, H, K E, H, K Pf
27 (M) 2 16 180 Kb A, H, K K Pk
28 (M) 2.5 6 115 H H HA, K H H
29 (F) 2 4 108 K Hb H, K
30 (F) 1 9 129 Hb K H
31 (M) 12 19 168 H Eb E, H, K
32 (M) 4.5 16 161 K, H H H
33 (F) 7 19 163 H H H H
34 (F) 1 23 157 K, H Fa, HAa H H, W H
35 (F) 1 12 150 H H Ej, HAj H
36 (F) 3 8 122 H, K Kb H, K Thg, Pf R279Wh
37 (F) 4 8 122 K Hb A, K Pk
38 (M) 5 12 130 H H H, K Th-Lg
39 (M) 12 31 162 H H, K, S Fi A, H, S E, HA, K H, K
40 (M) 9 12 150 K Hb, Kb H K Th-Lg
41 (M) 10 30 180 K, H K, Th-L Th-Lg InsT3IVS8m
NOTE.—A p ankles; E p elbows; F p feet; H p hips; HA p hands; K p knees; L p lumbar vertebral bodies; Pp patella; S p shoulders; SPp spine; Thp
thoracic vertebral bodies; W p wrists.
a Brachydactyly.
b Valgus/varus deformity.
c Crepitation.
d In the COMP gene.
e Lateral dislocation.
f Multipartite patella.
g Endplate irregularities.
h In the DTDST gene.
i Talipes deformities.
j Joint laxity.
k Developmental delay.
l Mild platyspondyly.
m In the COL9A1 gene.
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Blood samples were obtained from the probands and the
family members, for genomic DNA isolation. Signed in-
formed consent was obtained from all subjects.
Linkage Analysis
Intragenic markers or microsatellite markers were
used for linkage analysis of COL9A1, COL9A2,
COL9A3, and COMP. Three sequence variations were
tested in COL9A1: TrC in IVS212, CrT in IVS1988,
and ArG in IVS2061. The IVS2 variation was amplified
by PCR with the primers E3F (5′-GTG GTC AAT TGC
TAT TTT CTG GTT C) and E3R (5′-GCT TTA TCT
ACC TGG AAC TGA G), and the IVS19 and IVS20
variations were amplified with the primers E20F (5′-CCA
TCA GAA GAA TTC TCC TTG GAC) and E20R (5′-
GAT AAA AAG TTA TGT TTA AAT GGC). Primers
A19F (5′-TGG ATC TCA GTT TCC CTA CCT G) and
A19R (5′-CAA GAG GTG GTG ATT GAG CAA GAG
C) were used for PCR amplification of a region of the
COL9A2 gene that contained three single-nucleotide
variations: ArG in exon 1923, CrG in exon 1949, and
CrG in IVS184. In addition, microsatellite markers,
DIS211 and L-MYC, were used to analyze linkage to
chromosome 1 (Ma¨kela¨ et al. 1992; Weissenbach et al.
1992). The primer pair FI19C (5′-CAG AAT GGC GTG
CCA GGA CTC G) and RI19C (5′-CCA ACA TGG
GCC ACT GAG C) was used to amplify four single-
nucleotide variations in the COL9A3 gene by PCR;
GrC in IVS1890, CrT in IVS1910, GrC in IVS1912,
and GrA in IVS1958. The primer pair JC18F (5′-GGG
CTG GCC ACT GAA GCT CTG AGA) and JC18R
(GCC GCG GTG AGG GTG GCT GCT AT) was used
to amplify a single-nucleotide variation in the COMP
gene, TrC in IVS1853. A tetranucleotide repeat in IVS9
of the COMP gene had been reported elsewhere (Briggs
et al. 1995).
Mutation Screening and Sequencing
Exons and the boundaries of the COMP (Newton
et al. 1994; GenBank accession number AC003107),
COL9A1, COL9A2 (Pihlajamaa et al. 1998), and
COL9A3 (Paassilta et al. 1999b) genes were amplified
by PCR using 40 ng of genomic DNA, 0.25 mM of for-
ward and reverse primers, 1.5 mM MgCl2, 0.2 mM
dNTPs, and 1 U of AmpliTaq Gold polymerase (Perkin
Elmer). The PCR conditions included an initial dena-
turation for 10 min at 95C, followed by 35 cycles at
95C for 30 s, at 54C–63C for 30 s, and at 72C for
30 s, followed by 1 cycle at 72C for 10 min. This was
followed by denaturation at 98C for 3 min and rean-
nealing at 68C for 30 min, to generate heteroduplexes.
All PCR products were checked for quality and quantity
on 2% agarose gels.
Conformation-sensitive gel electrophoresis (CSGE)
was performed as described elsewhere (Ko¨rkko¨ et al.
1998), and the PCR products that contained hetero-
duplexes were sequenced using the dRhodamine Ter-
minator Cycle Sequencing Ready Reaction Kit and an
ABI Prism 377 Sequencer (Perkin Elmer), after prior
treatment with exonuclease and shrimp alkaline phos-
phatase (Werle et al. 1994).
A region of the DTDST gene containing the R279W
mutation was amplified by PCR with a primer pair that
has been described elsewhere (Huber et al. 2001). The
presence of the mutation was studied by digestion with
StyI restriction endonuclease.
RNA Analysis
Total RNA was extracted from Epstein-Barr virus
(EBV)–transformed lymphoblasts from proband 41.
First-strand cDNA synthesis (Superscript Preamplifica-
tion System [Gibco BRL]) was followed by PCR ampli-
fication with primers corresponding to exon 5 (D1F: 5′-
GCA GCC TTT TCG AAT TTG TCC TCC TTG) and
exon 19 (D1R: 5′-CTC CGA GTT CTC CCT GGT CAC
CTT CTT CAC) of the COL9A1 gene. A second am-
plification was performed using nested primers from
exon 6 (JV-9B: 5′-GAA ACT TGC CAT GAG CTG
CCA) and exon 11 (JV-8R: 5′-ATC CAT CAG GTC CTG
TTA AT). The products were analyzed on agarose gels
and by sequencing.
Results
Diagnosis
Initially, 59 probands had been selected for exami-
nation, on the basis of their clinical histories and clinical
findings, which were typical of MED. Radiographs were
taken of the ankles, elbows, hands, hips, knees, shoul-
ders, and spine and were evaluated independently by two
expert radiologists. After evaluation of the clinical and
radiological findings, a diagnosis of MED was confirmed
in 41 cases; the remaining eighteen probands were ex-
cluded because they were found to have bilateral Legg-
Calve-Perthes disease (MIM 150600), spondyloepiphy-
seal dysplasia tarda (MIM 184100), spondyloepimeta-
physeal dysplasia (MIM 300106) or mild to severe forms
of PSACH. The detailed clinical and radiological find-
ings regarding the probands are presented in table 1,
and radiographs of the knees and spine of proband 14
and of the hips of the proband’s affected brother are
shown in figure 1A–E.
Linkage Analysis
Of the cases of disease in the 41 probands, 25 were
sporadic and 16 were familial. Linkage to all four can-
didate genes, COL9A1, COL9A2, COL9A3 andCOMP,
was tested in the four largest families available (probands
12, 14, 20, and 32; table 1), yielding recombinations with
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Figure 1 Radiographs of the knees (A, anteroposterior (AP) view; B, lateral view) and thoraco-lumbar spine (C, AP view; D, lateral view)
of proband 14 at age 14 years (table 1), and of the hips (E) of the proband’s affected brother at age 11 years (individual R.B. in fig. 2). The
knee radiographs show irregular and flat epiphyses and multipartite patella. Endplate irregularities are seen in the thoraco-lumbar spine. The
radiographs of the hips show varus deformity, shortening of the femoral necks, enlarged and flat femoral heads, dysplastic acetabuli, and
dislocation of the left hip.
the MED phenotype in two of the families, and recom-
binations between COL9A2, COL9A3 andCOMP and
the phenotype in the other two (fig. 2).
Mutations and Polymorphisms in the COMP Gene
All probands except for numbers 12, 14, 20, and 32
(table 1 and fig. 2) were analyzed for mutations in
COMP. All 19 exons and exon boundaries of the gene
were amplified by PCR and were tested for sequence
variations by CSGE. Products that contained hetero-
duplexes in CSGE analyses were sequenced, leading to
the identification of three mutations (fig. 3). The rest of
the observed sequence variations were likely to be neu-
tral, because they did not change the amino acid encoded
and were also found in controls (not shown).
A novel ArC transversion was found in exon 12,
which changed a GAT codon for Asp420 to a GCT codon
for Ala in the sixth T3 repeat (fig. 3). This was found
in proband 2 (table 1) and in her two affected daughters,
who were aged 16 and 20 years, but not in any unaf-
fected family members or in the 100 controls tested. The
younger daughter had had knee pains since the age 7
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Figure 2 Pedigrees of four families with MED. Blackened symbols denote affected individuals. The probands are indicated by arrows
(↖). The family pedigree of proband 12 is shown in panel A, that of proband 14 in panel B, that of proband 20 in panel C, and that of proband
32 in panel D (table 1). Alleles of the markers are shown below the symbols.
years. Clinical examination revealed crepitation of the
knees, laxity of the knee joints, and mild scoliosis, while
radiological examination showed subchondral sclerosis,
flattening of the femoral heads, valgus deformity, short
femoral necks, and irregular and flat epiphyses of the
knees (not shown). Arthroscopy revealed a bipartite pa-
tella and chondromalacia patellae. Her older sister had
had hip pains since age 14 years and currently had knee
and elbow pains as well. A clinical examination revealed
valgus deformity of the forearms, hyperextension of the
elbows, joint laxity, crepitation of the knees, mild sco-
liosis, and mild shortening of the toes. Radiographs
showed valgus deformity of the femoral neck, mild flat-
tening of the femoral heads, irregular and flat knee
epiphyses, sclerosis of the acetabulum, and endplate ir-
regularities of the lumbar vertebral bodies (not shown).
A second mutation, identified in proband 8 (table 1),
consisted of a single-base change in exon 8 (fig. 3) that
converted a CCG codon for Pro276 to a CGG codon for
Arg in the first T3 repeat. Four other family members
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Figure 3 CSGE analysis of the PCR products for exons 8, 12,
and 16 of the COMP gene, and for exon 8 of the COL9A1 gene. “E”
denotes exon, “P” denotes proband, and “C” denotes control.
Figure 4 Agarose gel electrophoresis of a1(IX) reverse-tran-
scriptase PCR products. RNA was isolated from EBV-transformed
lymphoblasts from proband 41 and was analyzed for splicing by PCR
as indicated in the Subject and Methods section. The control sample
(C) shows one product of about 570 bp, whereas the sample from the
proband (RT) has two major products of about 570 and 430 bp. In
addition, two small minor products can be seen in the proband’s sam-
ple. “Wt” denotes wild type, “Del” denotes deletion, and “M” denotes
molecular weight marker.
were also affected: the proband’s mother and maternal
grandmother, an aunt, and an uncle. All of them had
the mutation, which was not found in any of the un-
affected family members. The mutation was not found
in any of the 100 controls tested. The proband’s mother
is 46 years old and 168 cm tall. She has had difficulties
in walking since age 15 years and had hip pain since
age 23 years. At the time of the present study, she also
had pain in the knees, shoulders, and wrists. Clinical
examination revealed crepitation of the shoulders, val-
gus deformity of the knees, and a limited range of motion
of the hips. Radiological examination showed severe hip
and knee OA, flattening of the femoral heads and knee
epiphyses, shortening of the femoral neck, and endplate
irregularities in the lumbar spine (not shown). The uncle
is 44 years old and 172 cm tall. He has had a waddling
gait and hip pain since age 3 years and has a limited
range of movement in his hips and knees. Radiological
examination revealed flattening of the knee epiphyses
with moderately severe OA, flat femoral heads with mul-
tiple subchondral cysts, varus deformity of the hips, and
short femoral necks (not shown). A diagnosis of MED
was confirmed in the other two affected individuals by
clinical and radiological examination.
The third mutation, affecting exon 16 in proband 10
(table 1, fig. 3), changed an ACG codon for Thr585 to
an ATG codon for Met in the C-terminal globular do-
main. None of the proband’s family members were af-
fected, nor did they carry the mutation, suggesting a de
novo mutation. The proband had had knee pain since
age 6 years and hip pain since age 12 years. The clinical
and radiological findings are presented in table 1. There
was no radiological evidence of metaphyseal or verte-
bral-body abnormalities.
Mutation Analysis of the COL9A1, COL9A2, and
COL9A3 Genes
All the probands in whom no mutations were found
or no recombinations were observed between the col-
lagen IX genes and the phenotype were analyzed for
sequence variations in the genes. Exons and the bound-
aries of the COL9A1, COL9A2, and COL9A3 genes
were amplified by PCR and were analyzed for hetero-
duplexes by CSGE. In addition, exons 2, 3, and 4 of the
COL9A2 and COL9A3 genes and exons 8, 9, and 10
of the COL9A1 gene were analyzed by sequencing.
Analysis of exon 8 of the COL9A1 gene in proband
41 identified a unique heteroduplex (table 1, fig. 3). Se-
quencing of the product showed insertion of a T at the
donor splice site of IVS83 (data not shown). The pres-
ence of the insertion was confirmed by digestion with
MseI restriction endonuclease (data not shown). The
proband’s affected mother also had the insertion,
whereas his unaffected sister did not. The insertion was
not found in any of 600 control chromosomes tested.
RNA isolated from the lymphoblasts of the affected son
and from a control sample was reverse transcribed and
amplified by PCR, using primers specific to exons 6 and
11. The products were first analyzed on agarose gels,
where the control sample always had only one band,
but the sample from the affected individual constantly
showed two major bands and one or more minor ones.
One of the major bands corresponded to the control
band in size, whereas the other one was ∼150 bp shorter
(fig. 4). Sequencing of the PCR products indicated that
the insertion resulted in at least three splicing defects
(not shown): one lacking sequences for exons 8 and 10,
and the other two lacking sequences for either exon 8
or exon 10. Skipping of exon 8, exon 10, or exons 8
and 10 leads to an in-frame deletion of 25, 21, or 46
amino acids, respectively, in the COL3 domain of the
a1(IX) chain.
The proband, now aged 30 years, has had knee pains
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Figure 5 Radiographs of the thoraco-lumbar spine (A, lateral view) and lumbar spine (B, lateral view) of proband 41 (table 1), and of
the left foot (C, AP view), hips (D, AP view), and left knee (E, AP view) of the proband’s affected mother. Radiographs of the spine show small
anterior osteophytes on several of the lower thoracic vertebrae and on L4. Radiographs of the proband’s mother show widespread and severe
OA in all joints.
and difficulty in walking since the age of 10 years, and
pain and stiffness in the knees had persisted. Radio-
graphs indicated evidence of early OA in the right knee,
Schmorl’s nodes, endplate irregularities, and anterior os-
teophytes in the thoraco-lumbar vertebrae, including cal-
cification of the intervertebral disc (fig. 5A and B). The
hips were normal, but the sacro-iliac joints were ill de-
fined. The proband’s mother had arthritis affecting her
hands, feet (fig. 5C), hips (fig. 5D), knees (fig. 5E), and
spine, with symptoms starting at age 45 years. She has
had a total knee replacement. The proband’s sister was
asymptomatic, but their maternal grandmother had bi-
lateral hip replacements.
Several sequence variations were identified, although
these were likely to be neutral, since they were also found
in controls. The variations that resulted in amino acid
changes are shown in table 2. One of the variations in
COL9A3, GrA resulting in the conversion of Arg to
Gln, was not found in any of the 109 controls tested.
This variation was found in proband 21 and in her un-
affected father. Thus, the variation most likely represents
a rare neutral sequence variant.
Analysis of the DTDST gene
Because a homozygous R279W DTDST mutation has
been reported in an individual with autosomal reces-
sively inherited MED characterized by club foot and/or
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Table 2
Amino Acid Variations in COL9A1, COL9A2, and COL9A3
GENE
AND EXON
NUCLEOTIDE
CHANGE
AMINO
ACID
CHANGE
ALLELE COUNTSa
Probandsb Controlsc
COL9A1:
11 1066TrC S339P 2/68 1/99
28 1913GrA R621Q 8/62 21/79
COL9A2:
14 780CrT T246M 4/66 2/98
19 1020ArG Q326R 12/58 23/93
19 1046CrG L335V 2/68 5/111
COL9A3:
5 324CrT R103W 5/65 7/93
5 325GrA R103Q 1/69 1/99
17 904CrT P296L 2/68 1/99
23 1222GrA R402Q 1/69 0/218
25 1321CrA A435E 12/58 22/78
a Allele count to the left of the slash is that of the polymorphic
allele, and the allele count to the right of the slash is that of the
wild-type allele. For instance, in the case of COL9A1 exon 11, 2
alleles were 1066T and 68 alleles were 1066C in the probands.
b Allele counts were determined from 35 probands. Allele counts
were not determined from probands 2, 8, 10, 14, 32, and 41.
c Allele counts were determined from 50 control subjects.
double-layered patella, we tested for the presence of the
mutation in the probands who had either multipartite
patella or talipes deformities (probands 3, 4, 5, 14, 17,
18, 22, 26, 36, and 39; table 1) by StyI restriction-en-
zyme digestion. No heterozygotes were found, but pro-
bands 3 and 36 were homozygous for the mutation (da-
ta not shown). The mutation was confirmed by sequenc-
ing (data not shown). The parents of probands 3 and
36 were unaffected. Samples from the parents were not
available for mutation analysis.
Discussion
MED is, clinically and radiologically, a highly heteroge-
neous disease for which five loci have so far been iden-
tified. Eleven mutations in COMP have been found in the
Ribbing, Fairbanks, and unclassified forms (Briggs et al.
1995, 1998; Ballo et al. 1997; Susic et al. 1997; Ikegawa
et al. 1998; Loughlin et al. 1998; Deere et al. 1999; De´lot
et al. 1999), and all of these mutations have been different
and have been located in different domains of the mol-
ecule, thus probably partially explaining the clinical het-
erogeneity. However, all of the mutations identified to date
in the other two genes,COL9A2 andCOL9A3, have had
the same consequence—that is, skipping of exon 3 and a
resulting in-frame deletion of 12 amino acids (Muragaki
et al. 1996; Holden et al. 1999; Paassilta et al. 1999a;
Bonneman et al. 2000; Lohiniva et al. 2000; Spayde et
al. 2000). All individuals with collagen IX splicing mu-
tations also share a very similar phenotype, typically
consisting of normal to near-normal height, as well as
epiphyseal dysplasia of the knees and some other joints
in childhood, but generally only OA of the knees in
adulthood.
The phenotypic heterogeneity of MED may also be
due to locus heterogeneity, a hypothesis supported by
the results of the present linkage analysis. The analysis
of four families with MED showed recombinations be-
tween the four candidate genes and the phenotype in
two of the families, and between three of the candidate
genes and the phenotype in the other two families. The
results of the mutation screening analysis further sup-
ported the possibility of locus heterogeneity. Surpris-
ingly, screening of the exon sequences and exon bound-
aries for the mutations in the four candidate genes,
COL9A1, COL9A2, COL9A3, and COMP, resulted in
the identification of only four mutations in the pro-
bands, a finding that suggests that mutations in collagen
IX and COMP do not explain the majority of MED
cases. Even though the CSGE method has proved to be
highly sensitive (Ko¨rkko¨ et al. 1998), it is possible that
some mutations have gone undetected. One of the lim-
itations of the method is that it does not detect large
deletions, and it is true that only point mutations or
small deletions have been reported in the genes for col-
lagen IX and COMP in patients with MED.
Of the three mutations found in COMP, two were
novel, and both were located in the T3 repeats, as has
been the case with most of the previously characterized
mutations (Briggs et al. 1995, 1998; Ballo et al. 1997;
Susic et al. 1997; Ikegawa et al. 1998; Loughlin et al.
1998; Deere et al. 1999). The third mutation, Thr585 to
Met in the C-terminal globular domain, has been de-
tected previously in a family with a mild form of PSACH
(Briggs et al. 1998). The finding that the same mutation
can lead to different but overlapping phenotypes is not
surprising. First, the various MED and PSACH forms
make up a phenotypic spectrum, and second, there are
several examples of the same mutations causing variable
phenotypes in different individuals—for example, col-
lagen I mutations in osteogenesis imperfecta (MIM
166210 and MIM 166200) (Ko¨rkko¨ et al. 1997). Phe-
notypic variation can be evident even among members
of one family, as was the case in one family with MED
family that had a COL9A3 mutation (Paassilta et al.
1999a).
The mutation in COL9A1 identified in one family rep-
resents the first human disease-causing mutation ever re-
ported in connection with this gene. Since COL9A1 con-
tains six additional exons coding for the longer NC4
domain compared with the two other collagen IX genes,
exon 9 of COL9A1 corresponds to exon 3 in the others.
For this reason, it was somewhat surprising that the mu-
tation, the insertion of a T at the donor splice site of
IVS83, did not result in skipping of exon 9. The finding
that it led to a complex splice pattern involving mainly
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exons 8 and 10 was not in itself surprising, however,
since mutations at donor splice sites have been shown to
lead to variable splice forms (Schwarze et al. 1999).
Although the exact phenotype of the two individuals
carrying the COL9A1 splicing mutation is unclear in
terms of whether cartilage degeneration typical of pri-
mary OA or of chondrodysplasia is the predominant fea-
ture, the phenotype of MED in the proband is supported
by a history of knee pain and walking difficulties in child-
hood, as well as by the nature of the mutation. It has
been shown elsewhere that a diagnosis of MED is difficult
to establish in adult patients, in the case of collagen IX
mutations (Muragaki et al. 1996; Holden et al. 1999;
Paassilta et al. 1999a; Bonneman et al. 2000; Lohiniva
et al. 2000; Spayde et al. 2000). Consequently, these mu-
tations should be considered when evaluating patients
with familial OA primarily affecting the knees.
Two additional loci, EDM4 and EDM5, have been
identified recently in patients with MED. EDM4 con-
tains the DTDST gene, in which a homozygous R279W
mutation was shown to cause recessively inherited MED
associated with club foot and double-layered patella
(Superti-Furga et al. 1999). The same homozygous mu-
tation was also reported in two sibships with apparently
isolated club foot (Huber et al. 2001). This mutation
was detected here in two probands with multipartite
patella. The EDM5 locus contains the MATN3 gene
(Chapman et al. 2001). Two different mutations were
reported very recently in this gene in two families with
autosomal dominant MED (Chapman et al. 2001).
Since this gene was not analyzed here, it is possible that
some of the probands in the present study may have
mutations in this gene.
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